Anzu Special Acquisition Corp I (NASDAQ: ANZUW) operates as a blank check company, or special purpose acquisition company (SPAC), formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, with a focus on high-quality companies featuring transformative technologies for industrial applications. Incorporated in 2020 and headquartered in Tampa, Florida, the company targets opportunities primarily across North America, Europe and Asia Pacific; it offers no current products or services beyond its SPAC structure of redeemable units comprising Class A common stock and warrants. In September 2023, Anzu completed a business combination with Envoy Medical Corporation, through which the combined entity operates as Envoy Medical, Inc. (NASDAQ: COCH), a hearing health innovator offering devices such as the Acclaim cochlear implant and others across the hearing loss spectrum, with subsequent registered direct offerings including a $2.5 million raise in 2025. As of December 2025, Anzu maintains independent trading of its warrants under ANZUW amid potential delisting risks for related securities, while its affiliate Anzu Partners pursues separate strategic moves, including a signed but unclosed asset purchase agreement for voxeljet AG's 3D printing business announced in December 2024, expected to close in 2025 subject to approvals that remain pending amid voxeljet's subsequent financial restructuring.